Sort
326,823 grants matching “clinical trial”
Baylor College of Medicine Cancer Center
$3,089,219C Kent Osborne · Baylor College Of Medicine · P30 · FY2010 · CA
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICS
$3,088,600Michael S. Saag · University Of Alabama At Birmingham · R24 · FY2010 · AI
American College of Radiology Imaging Network
$3,088,082Mitchell D Schnall · American College Of Radiology · U01 · FY2009 · CA
Assays to Support Development of Malaria Transmission Blocking Vaccines
$3,087,956Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Preventive and therapeutic T cell vaccines to mitigate HIV-1 replication; Preven
$3,087,817Genoveffa Franchini · Basic Sciences · Z01 · FY2007 · CA
MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS
$3,087,107Neelum T Aggarwal · Rush University Medical Center · R01 · FY2020 · AG
Quantifying and Treating Myofascial Dysfunction in Post Stroke Shoulder Pain
$3,086,679Preeti Raghavan · Johns Hopkins University · R33 · FY2024 · AT
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)
$3,085,778Raphael Dolin · Beth Israel Deaconess Medical Center · UM1 · FY2018 · AI
Single molecule study of C9ORF72 repeat RNA metabolisms in ALS/FTD
$3,085,325Shuying Sun · Johns Hopkins University · RF1 · FY2025 · NS
Clinical Trials Development Core
$3,085,146Peter J O'Dwyer · Ecog-Acrin Medical Research Foundation · U10 · FY2020 · CA
Providence/Boston Center for AIDS Research (CFAR)
$3,084,858Susan Cu-Uvin · Miriam Hospital · P30 · FY2020 · AI
Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations
$3,084,653Debra P Ritzwoller · Kaiser Foundation Research Institute · UM1 · FY2020 · CA
Protein Therapy for Recessive Dystrophic Epidermolysis Bullosa
$3,084,337Mei Chen · University Of Southern California · RC4 · FY2010 · AR
A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder
$3,083,969Steven M Cohen · Drug Delivery Company, Llc, The · UG3 · FY2019 · DA
SECONDARY PREVENTION OF SMALL SUBCORTICAL STROKES (SPSS)
$3,083,801Oscar R Benavente · University Of British Columbia · U01 · FY2009 · NS
SECONDARY PREVENTION OF SMALL SUBCORTICAL STROKES (SPS3)
$3,083,801Oscar R Benavente · University Of British Columbia · U01 · FY2010 · NS
SECONDARY PREVENTION OF SMALL SUBCORTICAL STROKES (SPSS)
$3,083,801Oscar R Benavente · University Of British Columbia · U01 · FY2010 · NS
UNIVERSITY OF MICHIGAN CANCER CENTER
$3,083,511University Of Michigan At Ann Arbor · P30 · FY2000 · CA
NINDS Center for Clinical Trial Research
$3,083,375 · N01 · FY2007 · NS
NINDS CENTER FOR CLINICAL TRIAL RESEARCH DATA MANGEMENT, METHODOLOGY, STATISTCIA
$3,083,375Selma Kunitz · · N01 · FY2007 · NS
CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE
$3,083,340Christina Wang · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · N01 · FY2015 · HD
HEAL: New Chemical Structures for Pain, Addiction and Overdose Targets
$3,082,914Samuel Michael · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
ECOG CCOP Research Base
$3,082,867Robert L Comis · Frontier Sci & Technology Rsch Fdn, Inc · U10 · FY2007 · CA
Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients
$3,082,804Jonathan Kil · Sound Pharmaceuticals, Inc. · U01 · FY2021 · TR
Exercise and Intensive Vascular Risk Reduction in Preventing Dementia
$3,082,775Rong Zhang · Ut Southwestern Medical Center · R01 · FY2016 · AG